Kaempferol 3-neohesperidoside
CAS No. 32602-81-6
Kaempferol 3-neohesperidoside( Kaempferol 3-O-neohesperidoside )
Catalog No. M24260 CAS No. 32602-81-6
Kaempferol 3-neohesperidoside is a flavonoid. Kaempferol 3-neohesperidoside exhibits insulinomimetic effect on the rat soleus muscle.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 144 | In Stock |
|
| 10MG | 212 | In Stock |
|
| 25MG | 356 | In Stock |
|
| 50MG | 528 | In Stock |
|
| 100MG | 755 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKaempferol 3-neohesperidoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionKaempferol 3-neohesperidoside is a flavonoid. Kaempferol 3-neohesperidoside exhibits insulinomimetic effect on the rat soleus muscle.
-
DescriptionKaempferol 3-neohesperidoside is a flavonoid. Kaempferol 3-neohesperidoside exhibits insulinomimetic effect on the rat soleus muscle.
-
In Vitro——
-
In Vivo——
-
SynonymsKaempferol 3-O-neohesperidoside
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3|MEK|PI3K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number32602-81-6
-
Formula Weight594.5
-
Molecular FormulaC27H30O15
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (84.10 mM)
-
SMILESC[C@@H]([C@@H]([C@H]([C@H]1O)O)O)O[C@H]1O[C@H]([C@H]1O)[C@H](OC2=C(c(cc3)ccc3O)Oc(cc(cc3O)O)c3C2=O)O[C@H](CO)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Insulinomimetic effect of kaempferol 3-neohesperidoside on the rat soleus muscle.J Nat Prod. 2008 Apr;71(4):532-5.
molnova catalog
related products
-
5-Bromoindole
5-bromoindole is a potential inhibitor of glycogen synthase kinase 3 (GSK-3)and an important pharmaceutical chemical intermediate.
-
GSK-3 inhibitor 4
GSK-3 inhibitor 4 is an orally active and brain-permeable compound that acts as a triple inhibitor of GSK-3, CDK2, and CDK5, with IC50 values of 0.56 nM (GSK-3β), 0.45 nM (GSK-3α), 0.47 μM (CDK2), and 0.68 μM (CDK5).
-
MeBIO
MeBIO is an agonist of aryl hydrocarbon receptor, with IC50 of 44 and 55 μM for GSK-3 and CDK1/CyclinB, respectively. MeBIO does not affect GSK-3β.
Cart
sales@molnova.com